Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Dan L Duncan Comprehensive Cancer Center at Baylor St.

Luke's Medical Center is dedicated to delivering high quality, compassionate care to Houston and nearby communities. The Center brings together all of our cancer-related activities under one umbrella, fast-tracking our efforts to prevent and ultimately cure cancer.

Several of our surgical oncologists share how robotic-assisted Whipple surgery is changing pancreatic cancer care.
08/18/2025

Several of our surgical oncologists share how robotic-assisted Whipple surgery is changing pancreatic cancer care.

Baylor Medicine surgeons discuss how robotic-assisted Whipple surgery is changing pancreatic cancer care.

Dr. Livia Eberlin explains how the MasSpec Pen could help address the missing link in point-of-care oncology.
08/15/2025

Dr. Livia Eberlin explains how the MasSpec Pen could help address the missing link in point-of-care oncology.

For many cancers, surgical resection is the primary treatment option. However, traditional tissue analysis is slow and error-prone; point-of-care MS tools like the MasSpec Pen could improve cancer detection.

Patient Ronald Lackey shares how Dr. William Fisher helped him beat his pancreatic cancer diagnosis.
08/13/2025

Patient Ronald Lackey shares how Dr. William Fisher helped him beat his pancreatic cancer diagnosis.

Learn more about cancer survivor Ronald Lackey and his journey with pancreatic cancer with the help of Dr. William Fisher.

August is National Immunization Awareness Month and Dr. Claire Hoppenot talks about how the human papillomavirus vaccine...
08/11/2025

August is National Immunization Awareness Month and Dr. Claire Hoppenot talks about how the human papillomavirus vaccine can help prevent cervical cancer.

Gynecologic oncologists at Baylor College of Medicine discuss how HPV vaccination can lead to the prevention of cervical cancer.

Take a closer at Barrett’s esophagus and how it can increase the risk of developing esophageal adenocarcinoma.
08/08/2025

Take a closer at Barrett’s esophagus and how it can increase the risk of developing esophageal adenocarcinoma.

This microscopy view of tissue lining the esophagus shows the distinctive characteristics of Barrett's esophagus next to normal tissue.

Dr. Hashem El-Serag stopped by All Things Considered to talk about the recent Lancet Commision findings on liver cancer....
08/06/2025

Dr. Hashem El-Serag stopped by All Things Considered to talk about the recent Lancet Commision findings on liver cancer.

A new study of liver cancer shows three ways to reduce the risk in the majority of cases. We learn more about what they are and what else the study found.

Researchers take a closer look at why some muscle-invasive bladder cancer tumors are resistant to chemotherapy by conduc...
08/04/2025

Researchers take a closer look at why some muscle-invasive bladder cancer tumors are resistant to chemotherapy by conducting a detailed molecular analysis of these tumors.

About one quarter of patients with muscle-invasive bladder cancer (MIBC) may be treated and derive a benefit with the current standard chemotherapy. To...

Today is World Lung Cancer Day. Dr. Robert Taylor Ripley discusses common causes of lung cancer, risks and the latest tr...
08/01/2025

Today is World Lung Cancer Day. Dr. Robert Taylor Ripley discusses common causes of lung cancer, risks and the latest treatments.

Dr. Robert Taylor Ripley discusses common causes of lung cancer, risks and the latest treatments.

07/29/2025

New analysis from the The Lancet Commission on liver cancer finds that 60% of cases are caused by preventable risk factors. The Commission, which includes Center member Dr. Hashem El-Serag, highlights several ways to reduce these risks factors.

Liver cancer is the sixth most common cancer and the third leading cause of cancer-related mortality globally. The number of new liver cancers will nearly double, from 0·87 million in 2022 to 1·52 million in 2050, if there is no change in the current trend. The Lancet Commission on hepatocellular ...

Study reveals heterogeneity of bone metastases across different and same cancer types.
07/25/2025

Study reveals heterogeneity of bone metastases across different and same cancer types.

The results of this study suggest a need to investigate different treatment strategies for different immune ecosystem patterns in bone metastases.

Dr. Arianexys Aquino-Lopez received a St. Baldrick's Foundation Scholar Grant for research using virus-specific T cells ...
07/23/2025

Dr. Arianexys Aquino-Lopez received a St. Baldrick's Foundation Scholar Grant for research using virus-specific T cells to attack osteosarcoma.

We’re celebrating a big win — and it’s all thanks to YOU. Because of your passion, generosity, and commitment to kids with cancer, the St. Baldrick’s Foundation is granting $10 million to fund groundbreaking childhood cancer research. Let that sink in: 26 projects. 22 institutions. One missi...

Address

1919 Old Spanish Trail
Houston, TX
77054

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Alerts

Be the first to know and let us send you an email when Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Category

Our Story

Dan L Duncan Comprehensive Cancer Center at Baylor St. Luke's Medical Center is dedicated to delivering high quality, compassionate care to Houston, TX and nearby communities. Visit us at 7200 Cambridge St or call (713) 798-2262 for more information. As one of only three NCI-designated Comprehensive Cancer Centers in Texas, the DLDCCC is one of the best in the country and is able to contribute vital advances to cancer research through national funding. Specialized health care providers at the DLDCCC are dedicated to understanding, preventing, and treating this disease.